Israel Englander’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-544,856
| Closed | -$25.6M | – | 6457 |
|
|
2025
Q2 | $25.6M | Buy |
544,856
+40,988
| +8% | +$1.82M | 0.01% | 1347 |
|
|
2025
Q1 | $22.2M | Buy |
+503,868
| New | +$23.2M | 0.01% | 1408 |
|
|
2024
Q4 | – | Sell |
-75,613
| Closed | -$2.64M | – | 6446 |
|
|
2024
Q3 | $2.42M | Buy |
75,613
+60,899
| +414% | +$2.28M | ﹤0.01% | 3533 |
|
|
2024
Q2 | $554K | Sell |
14,714
-690,825
| -98% | -$29.1M | ﹤0.01% | 4527 |
|
|
2024
Q1 | $34.7M | Buy |
705,539
+671,334
| +1,963% | +$31M | 0.01% | 1078 |
|
|
2023
Q4 | $1.25M | Sell |
34,205
-80,718
| -70% | -$2.11M | ﹤0.01% | 3976 |
|
|
2023
Q3 | $2.66M | Buy |
+114,923
| New | +$3.14M | ﹤0.01% | 3292 |
|
|
2023
Q2 | – | Sell |
-149,655
| Closed | -$3.93M | – | 6670 |
|
|
2023
Q1 | $3.85M | Buy |
149,655
+13,409
| +10% | +$392K | ﹤0.01% | 2840 |
|
|
2022
Q4 | $3.54M | Sell |
136,246
-34,351
| -20% | -$846K | ﹤0.01% | 3091 |
|
|
2022
Q3 | $4.87M | Buy |
170,597
+106,925
| +168% | +$3.07M | ﹤0.01% | 2910 |
|
|
2022
Q2 | $1.57M | Buy |
+63,672
| New | +$2.33M | ﹤0.01% | 3948 |
|
|
2022
Q1 | – | Sell |
-14,990
| Closed | -$929K | – | 7476 |
|
|
2021
Q4 | $929K | Sell |
14,990
-30,767
| -67% | -$2.04M | ﹤0.01% | 4477 |
|
|
2021
Q3 | $2.9M | Buy |
+45,757
| New | +$3.53M | ﹤0.01% | 3473 |
|
|
2021
Q2 | – | Sell |
-77,990
| Closed | -$5.74M | – | 7087 |
|
|
2021
Q1 | $5.74M | Sell |
77,990
-42,403
| -35% | -$3.32M | ﹤0.01% | 2425 |
|
|
2020
Q4 | $8.73M | Sell |
120,393
-38,812
| -24% | -$2.5M | 0.01% | 1879 |
|
|
2020
Q3 | $7.59K | Sell |
159,205
-132,803
| -45% | -$5.66M | 0.01% | 1487 |
|
|
2020
Q2 | $12.3M | Buy |
292,008
+231,248
| +381% | +$8.23M | 0.02% | 1071 |
|
|
2020
Q1 | $1.64M | Buy |
60,760
+55,037
| +962% | +$1.79M | ﹤0.01% | 2150 |
|
|
2019
Q4 | $220K | Sell |
5,723
-397,890
| -99% | -$9.31M | ﹤0.01% | 3829 |
|
|
2019
Q3 | $8.75M | Buy |
+403,613
| New | +$9.54M | 0.01% | 1370 |
|
Other funds holding SWTX
Israel Englander's SWTX Position: Q3 2025 in Review
Israel Englander sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 544,856 shares — an estimated $25.6M sold.
Israel Englander first reported a position in SWTX in Q3 2019 and held it in 20 quarters. The position peaked at $34.7M in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.
- Israel Englander reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
- Israel Englander sold 544,856 SpringWorks Therapeutics shares in Q3 2025, an estimated $25.6M.
- Israel Englander first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 20 quarters.
- Israel Englander's SpringWorks Therapeutics position peaked at $34.7M in Q1 2024.
- 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.